FDA Issues Import Alert for Higenamine Supplements

On March 12, 2021 the U.S. Food and Drug Administration (FDA) published Import Alert 54-18, which relates to the detention without physical examination (DWPE) of dietary supplements and bulk dietary ingredients that are or contain higenamine, a dietary ingredient found on FDA’s Dietary Supplement Ingredient Advisory List (“DSIA List”).  Import Alert 54-18 prohibits two Chinese... Continue Reading